Ebos Group (ASX:EBO) COGS-to-Revenue : 0.88 (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ebos Group COGS-to-Revenue?

Ebos Group's Cost of Goods Sold for the six months ended in Dec. 2023 was A$5,772 Mil. Its Revenue for the six months ended in Dec. 2023 was A$6,589 Mil.

Ebos Group's COGS to Revenue for the six months ended in Dec. 2023 was 0.88.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Ebos Group's Gross Margin % for the six months ended in Dec. 2023 was 12.40%.

Ebos Group COGS-to-Revenue Historical Data

The historical data trend for Ebos Group's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group COGS-to-Revenue Chart

Ebos Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

COGS-to-Revenue

Get a 7-Day Free Trial

0.88

0.89

0.88

0.87

Ebos Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
COGS-to-Revenue	Get a 7-Day Free Trial															-	1.66	0.87	0.87	0.88

Ebos Group COGS-to-Revenue Calculation

Ebos Group's COGS to Revenue for the fiscal year that ended in Jun. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	10620.62	/	12173.616
	=	0.87

Ebos Group's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue	=	Cost of Goods Sold	/	Revenue
	=	5772.48	/	6589.453
	=	0.88

Ebos Group (ASX:EBO) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Ebos Group's Gross Margin % for the six months ended in Dec. 2023 is calculated as:

Gross Margin %	=	1	-	COGS to Revenue
	=	1	-	Cost of Goods Sold / Revenue
	=	1	-	5772.48 / 6589.453
	=	12.40 %

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Ebos Group COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Ebos Group's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group (ASX:EBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (ASX:EBO) » Definitions » COGS-to-Revenue

Comparable Companies

Traded in Other Exchanges

EBO:New Zealand EJG:Germany

Address

108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (ASX:EBO) Headlines

No Headlines